Asston Pharmaceuticals Ltd (544445) — Insider Trading | 1 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Insider sold 1,20,000 shares worth ₹6 crores
💡 Investor Takeaway
The sale may signal reduced confidence in near-term growth prospects.

Asston Pharmaceuticals disclosed an insider transaction on 31 August 2026 involving Mrs. Prakruti R Pali, who sold 1,20,000 shares valued at ₹6 crores, reducing her stake to 2.8% from 3.5%.

📄 View Original Announcement (PDF)

About Asston Pharmaceuticals Ltd (544445)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹106.01 Cr

View full 544445 stock details →

📡 Get AI alerts when 544445 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 544445 — Free

📊 More 544445 filings

See all 544445 filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day